- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06299423
Perioperative Monitoring to Assess Preoperative Anxiety in Inflammatory Bowel Disease Patients (PeRseo)
Perioperative Electrocardiogram Remote Monitoring to Assess Preoperative Psychological Distress and Improve Postoperative Recovery in Inflammatory Bowel Disease Surgery: a Pilot Single-arm Prospective Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Inflammatory Bowel Disease (IBD) patients are at high risk of postoperative complications and delayed recovery. Preoperative anxiety and low patient's awareness of the disease may increase the risk of postoperative complications inducing an autonomic impairment which may in turn determine an inflammatory unbalance. This correlation can be confirmed through the preoperative monitoring of the autonomic function- with wearable electrocardiogram (ECG) devices. The Howdy Senior® device (ComfTech Srl) allows the real-time remote ECG monitoring and the computation of stress and fatigue indexes.
The Howdy Senior® device may also provide a reliable tool for remotely monitoring the patient's clinical parameters after discharge.
This study aims to explore the pathophysiological mechanisms linking preoperative anxiety and autonomic response and assess the feasibility and effectiveness of the Howdy Senior® device for the postoperative patients' remote monitoring.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Annalisa Maroli, PhD
- Phone Number: 0039 02 8224 7776
- Email: colorapp@humanitas.it
Study Locations
-
-
MI
-
Rozzano, MI, Italy, 20089
- Recruiting
- Irccs Humanitas Research Hospital
-
Contact:
- Annalisa Maroli, PhD
- Phone Number: 0039 02 8224 7776
- Email: colorapp@humanitas.it
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients aged more than 18 years old.
- Established Crohn's disease (CD) or Ulcerative Colitis (UC) at the time of surgery indication with a proven histological diagnosis.
- Patients scheduled for elective intestinal resection.
Exclusion Criteria:
- Diagnosis of Undetermined Colitis.
- Recurrent disease.
- Concomitant diagnosis of malignancy.
- Established diagnosis of major depressive disorder or anxiety disorder.
- Diagnosis of ventricular or supraventricular arrythmia.
- Active pharmacological treatment with β-blockers or other drugs affecting the heart rate.
- Known hypersensitivity to cotton or silver.
- Emergent surgery.
- Planned open surgery.
- Any concomitant surgery unrelated to the main surgical indication. Patients undergoing perianal surgery for related perianal disease can be included in the study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Non-Randomized
- Interventional Model: Sequential Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Howdy Senior® device
Patients will undergo standard perioperative management.
Additionally, patients will perform three preoperative and twelve postoperative HOWDY Senior® assessments.
The assessment consists of a nocturnal electrocardiogram (ECG) measure and a morning rest Heart Rate Variability (HRV) measure of five minutes.
|
Standard perioperative management plus three preoperative and twelve postoperative (until 90 days after surgery) HOWDY Senior® device assessments.
|
|
No Intervention: Standard perioperative management
Patients belonging to the historical cohort of comparison, who underwent standard perioperative management and surgical intervention between January 2021 and January 2022.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Correlation between preoperative anxiety and preoperative Heart Rate Variability (HRV)
Time Frame: From 14 days to 1 day before surgery
|
Correlation between preoperative anxiety- assessed through the Hospital Anxiety and Depression Scale (HADS) (Self-reporting scale ranging from 0 to 21, where significant anxiety and depression are identified by a 8 point cut-off) and the median value of at least three Heart Rate Variability (HRV) measures collected in the preoperative period through the Howdy Senior® device.
|
From 14 days to 1 day before surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Correlation between preoperative anxiety and 90-day Comprehensive Complication Index (CCI)
Time Frame: 90 days after surgery
|
Correlation between preoperative anxiety- assessed through the Hospital Anxiety and Depression Scale (HADS) (Self-reporting scale ranging from 0 to 21, where significant anxiety and depression are identified by a 8 point cut-off) and the median value of the Comprehensive Complication Index (CCI) (Index ranging from 0 (no complication) to 100 (death)) at 90 days after the surgical intervention
|
90 days after surgery
|
|
Correlation between preoperative anxiety and C-Reactive Protein (CRP) level 24 hour after surgery
Time Frame: 24 hours after surgery
|
Correlation between preoperative anxiety- assessed through the Hospital Anxiety and Depression Scale (HADS) (Self-reported scale ranging from 0 to 21, where significant anxiety and depression are identified by a 8 point cut-off) and the level of serum C-Reactive Protein (CRP, µg/mL) measured 24 hours after surgery.
|
24 hours after surgery
|
|
90-day postoperative complications
Time Frame: 90 days after surgery
|
Rate difference of 90-day postoperative complications (classified according to the Clavien-Dindo scale) between the interventional cohort and the historical cohort of comparison.
|
90 days after surgery
|
|
Healthcare costs
Time Frame: 6 months after surgery
|
Median difference of the healthcare resources used in the interventional cohort and the historical cohort of comparison.
|
6 months after surgery
|
|
Correlation between preoperative anxiety and preoperative Patient Health Engagement Scale (PHE-S)
Time Frame: From 14 days to 1 day before surgery
|
Correlation between preoperative anxiety- assessed through the Hospital Anxiety and Depression Scale (HADS) (Self-reported scale ranging from 0 to 21, where significant anxiety and depression are identified by a 8 point cut-off) and the preoperative Patient Health Engagement Scale (PHE-S, self-reporting scale ranging from 0 (complete disease awareness) to 12 (complete absence of disease awareness).
|
From 14 days to 1 day before surgery
|
|
Correlation between the 90-day Postoperative Recovery Profile (PRP) and 90-day Heart Rate Variability (HRV)
Time Frame: 90 days after surgery
|
Correlation between the 90-day Postoperative Recovery Profile (PRP) (Scale ranging from 0 (completely recovered) to 68 (not recovered)) and the median value of at least twelve Heart Rate Variability (HRV) measures collected in the postoperative period through the Howdy Senior® device.
|
90 days after surgery
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Antonino Spinelli, MD, PhD, IRCCS Huamanitas Research Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 3677
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Inflammatory Bowel Diseases
-
Cook Children's Health Care SystemNot yet recruitingIBD | IBD - Inflammatory Bowel Disease | IBD (Inflammatory Bowel Disease)United States
-
Ningbo Medical Center Lihuili HospitalRecruitingInflammatory Bowel Disease (IBD)China
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaRecruitingIBD - Inflammatory Bowel DiseaseItaly
-
Chang Kyun LeeChonnam National University Hospital; Kyungpook National University Hospital; Chung-Ang University Hosptial, Chung-Ang University College of Medicine and other collaboratorsRecruitingInflammatory Bowel Disease (IBD)Korea, Republic of
-
Xijing HospitalNot yet recruitingInflammatory Bowel Diseases (IBD)China
-
Assiut UniversityNot yet recruitingInflammatory Bowel Disease (IBD)
-
University of British ColumbiaCompletedInflammatory Bowel Disease 11Canada
-
University of ChicagoTerminatedInflammatory Bowel Disease (IBD)United States
-
University of Texas Southwestern Medical CenterEnrolling by invitationInflammatory Bowel Disease | Inflammatory Bowel Disease (IBD)United States
-
University Hospital, GrenobleInstitute for Advanced Biosciences (IAB), GrenobleNot yet recruitingInflammatory Bowel Disease (IBD)France
Clinical Trials on Howdy Senior® device
-
University Hospital, BordeauxNot yet recruiting
-
Kepler University HospitalCompletedCholecystolithiasisAustria
-
Perrigo CSCINot yet recruiting
-
PathMaker Neurosystems Inc.National Institute of Neurological Disorders and Stroke (NINDS); Spaulding...TerminatedStroke | Muscle SpasticityUnited States
-
Medtronic Neurovascular Clinical AffairsCompletedIschemic StrokeUnited States
-
Cefaly TechnologyCompleted
-
Catholic University of the Sacred HeartUnknown
-
Association APPROCHESociété Neuradom; IMT Atlantique BrestRecruitingIschemic Stroke | Hemorrhagic Unilateral Cortico-subcortical Hemispheric StrokeFrance
-
Alejandro BerensteinRecruitingIntracranial Arteriovenous Malformations | Arterio-venous FistulaUnited States
-
David A. TalanLight AI, Inc.CompletedGroup A Streptococcal InfectionUnited States